Workers assemble vehicles in the FAW Jiefang assembly workshop. [Photo/Changchun Release]

Manufacturers are streaming back in overwhelming numbers to reach full production in Changchun, capital city of Northeast China's Jilin province, according to local media reports.

The reports said that as of May 5, a total of 1,265 industrial enterprises above a designated size – those with annual revenue of 20 million yuan ($2.98 million) or more – had resumed operations, with an output resumption rate of 95 percent and 248,000 employees returning to work.

The 66 industrial enterprises above a designated size that had not resumed work had already made production scheduling plans and will start "point-to-point" closed-loop commuting and resumption of work as soon as possible, the reports added.

After the outbreak of the COVID-19 epidemic, Changchun drafted and issued plans to ensure the work and production of major local businesses.

Measures were taken to ensure output, including point-to-point shuttle bus transfers.

At the same time, Changchun strengthened its nucleic acid testing, provision of traditional Chinese medicine and epidemic prevention systems.

It promoted the orderly operation of production chains and supply chains for key enterprises such as China FAW Group and CRRC Changchun Railway Vehicles.

FAW Group fully resumed work and production on April 18.

The daily output of FAW's five plants in Changchun has now increased to more than 4,000 vehicles. Since the resumption of work, a total of 33,000 vehicles have been produced in the city.

Changchun Gensci Pharmaceutical Co, one of the local enterprises, officially resumed production on April 15 with an average daily output value of 20.43 million yuan.